Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v8-EN
Language French English
Date Updated 2018-02-15 2018-02-15
Drug Identification Number 02347512 02347512
Brand name MYLAN-CARVEDILOL MYLAN-CARVEDILOL
Common or Proper name CARVEDILOL CARVEDILOL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CARVEDILOL CARVEDILOL
Strength(s) 3.125MG 3.125MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code C07AG C07AG
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-12-01 2017-12-01
Actual discontinuation date 2017-12-01 2017-12-01
Remaining supply date 2017-12-01 2017-12-01
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Last Lot # 3063832 and Expires 28-Feb-18. Resolved/discontinued in ID 9261 Last Lot # 3063832 and Expires 28-Feb-18. Resolved/discontinued in ID 9261
Health Canada comments